SYNLOGIC, INC. Cash
SYNLOGIC, INC. (SYBX) had Cash of $79.17 million as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2017-11-13
- 2017-09-30: Cash $79.17M.
- 2016-12-31: Cash $14.59M.
- 2016-09-30: Cash $21.50M.
- 2015-12-31: Cash $6.18M.
| Period end | Cash |
|---|---|
| 2017-09-30 | $79.17M 10-Q · filed 2017-11-13 |
| 2016-12-31 | $14.59M 10-Q · filed 2017-11-13 |
| 2016-09-30 | $21.50M 10-Q · filed 2017-11-13 |
| 2015-12-31 | $6.18M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |